{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:12:20Z","timestamp":1792213940332,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1006\/nbdi.2001.0395","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T15:46:43Z","timestamp":1032364003000},"page":"492-503","source":"Crossref","is-referenced-by-count":88,"title":["Corticotropin-Releasing Hormone Protects Neurons against Insults Relevant to the Pathogenesis of Alzheimer's Disease"],"prefix":"10.1006","volume":"8","author":[{"given":"Ward A.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"McCullers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Culmsee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman J.","family":"Haughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.2001.0395_RF1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1006\/nbdi.2001.0395_RF2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/378284a0","article-title":"Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease","volume":"378","author":"Behan","year":"1995","journal-title":"Nature"},{"key":"10.1006\/nbdi.2001.0395_RF3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1471-4159.1997.68052053.x","article-title":"Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF\/CRF-BP complex in Alzheimer's disease and control postmortem human brain","volume":"68","author":"Behan","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2001.0395_RF4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-3806(98)00130-8","article-title":"The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation","volume":"111","author":"Brunson","year":"1998","journal-title":"Dev. Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0028-3908(98)00173-7","article-title":"Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line","volume":"38","author":"Bundey","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1006\/nbdi.2001.0395_RF6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/6374","article-title":"Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice","volume":"2","author":"Chapman","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/jm960861b","article-title":"Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: A centrally active corticotropin-releasing factor1 receptor antagonist","volume":"40","author":"Chen","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1006\/nbdi.2001.0395_RF8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35046031","article-title":"A learning deficit related to age and \u03b2-amyloid plaques in a mouse model of Alzheimer's disease","volume":"408","author":"Chen","year":"2000","journal-title":"Nature"},{"key":"10.1006\/nbdi.2001.0395_RF9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/8438","article-title":"Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation","volume":"5","author":"Chui","year":"1999","journal-title":"Nat. Med."},{"key":"10.1006\/nbdi.2001.0395_RF10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/74255","article-title":"Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2","volume":"24","author":"Coste","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2001.0395_RF11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0006-8993(00)02759-1","article-title":"Influence of corticotrophin releasing factor on neuronal death in vitro and in vivo","volume":"881","author":"Craighead","year":"2000","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(93)90868-N","article-title":"Cell loss in supraoptic and paraventricular nucleus in Alzheimer's disease","volume":"609","author":"de Lacalle","year":"1993","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0306-4530(95)00011-9","article-title":"Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders","volume":"20","author":"De Souza","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1006\/nbdi.2001.0395_RF14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0006-8993(00)02576-2","article-title":"A biphasic regulation of receptor mRNA expressions for growth hormone, glucocorticoid and mineralocorticoid in the rat dentate gyrus during acute stress","volume":"874","author":"Fujikawa","year":"2000","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal A\u03b242 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1006\/nbdi.2001.0395_RF16","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1523\/JNEUROSCI.17-11-04212.1997","article-title":"Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid \u03b2-peptide: Involvement of calcium and oxyradicals","volume":"17","author":"Guo","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1096\/fasebj.13.1.115","article-title":"Plasticity of hippocampal corticosteroid receptors during aging in the rat","volume":"13","author":"Hassan","year":"1999","journal-title":"FASEB J."},{"key":"10.1006\/nbdi.2001.0395_RF18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0197-4580(94)00159-6","article-title":"Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease","volume":"16","author":"Hatzinger","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/nbdi.2001.0395_RF19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0531-5565(98)00045-X","article-title":"Transgenic mice expressing Alzheimer amyloid precursor proteins","volume":"33","author":"Hsiao","year":"1998","journal-title":"Exp. Gerontol."},{"key":"10.1006\/nbdi.2001.0395_RF20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1006\/nbdi.2001.0395_RF21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","volume":"56","author":"Irizarry","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.2001.0395_RF22","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1210\/en.138.11.4774","article-title":"Regulation of CRF messenger RNA and CRF peptide in the amygdala: Studies in primary amygdalar cultures","volume":"138","author":"Kasckow","year":"1997","journal-title":"Endocrinology"},{"key":"10.1006\/nbdi.2001.0395_RF23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/74271","article-title":"Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2","volume":"24","author":"Kishimoto","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2001.0395_RF24","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.17-13-05089.1997","article-title":"Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis","volume":"17","author":"Kruman","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/exnr.2000.7512","article-title":"Dietary restriction selectively decreases glucocorticoid receptor expression in the hippocampus and cerebral cortex of rats","volume":"166","author":"Lee","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2001.0395_RF26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/me.14.1.147","article-title":"Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of nonamyloidogenic amyloid \u03b2 precursor protein and with suppression of nuclear factor-\u03baB","volume":"14","author":"Lezoualc'h","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1006\/nbdi.2001.0395_RF27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-8993(91)91310-W","article-title":"Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury","volume":"545","author":"Lyons","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-8993(96)01207-3","article-title":"Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure","volume":"744","author":"Maecker","year":"1997","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)00025-3","article-title":"Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist","volume":"323","author":"Mansbach","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/nbdi.2001.0395_RF30","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1523\/JNEUROSCI.15-09-06239.1995","article-title":"Amyloid \u03b2-peptide impairs ion-motive ATPase activities: Evidence for a role in loss of neuronal Ca2+ homeostasis and cell death","volume":"15","author":"Mark","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","article-title":"A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid \u03b2-peptide","volume":"68","author":"Mark","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2001.0395_RF32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","article-title":"Amyloid \u03b2-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation","volume":"17","author":"Mark","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of \u03b2-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1006\/nbdi.2001.0395_RF34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"\u03b2-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/mcne.1994.1050","article-title":"The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat","volume":"5","author":"Morano","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0306-4522(98)00732-5","article-title":"Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain","volume":"92","author":"Morin","year":"1999","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2001.0395_RF37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-3223(95)00173-5","article-title":"Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease","volume":"39","author":"N\u00e4sman","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1006\/nbdi.2001.0395_RF38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S0033291700033675","article-title":"Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease","volume":"26","author":"O'Brien","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1006\/nbdi.2001.0395_RF39","first-page":"425","article-title":"Physiology and pharmacology of corticotropin-releasing factor","volume":"43","author":"Owens","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1006\/nbdi.2001.0395_RF40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.1998.6890","article-title":"The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells","volume":"155","author":"Pedersen","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2001.0395_RF41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/JMN:13:1-2:159","article-title":"Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease","volume":"13","author":"Pedersen","year":"1999","journal-title":"J. Mol. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1096\/fasebj.14.7.913","article-title":"The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis","volume":"14","author":"Pedersen","year":"2000","journal-title":"FASEB J."},{"key":"10.1006\/nbdi.2001.0395_RF43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1749-6632.1999.tb08687.x","article-title":"Corticotropin releasing factor receptors and their ligand family","volume":"885","author":"Perrin","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1006\/nbdi.2001.0395_RF44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0006-8993(97)01219-5","article-title":"Increased corticotropin-releasing factor immunoreactivity in select brain sites following kainate-elicited seizures","volume":"781","author":"Piekut","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s004010051127","article-title":"Corticotropin-releasing factor immunolabelled fibers in brain regions with localized kainate neurotoxicity","volume":"98","author":"Piekut","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1006\/nbdi.2001.0395_RF46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0006-3223(89)90071-1","article-title":"CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: Its relationship to severity of dementia and monoamine metabolites","volume":"26","author":"Pomara","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1006\/nbdi.2001.0395_RF47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/syn.890010504","article-title":"Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease","volume":"1","author":"Powers","year":"1987","journal-title":"Synapse"},{"key":"10.1006\/nbdi.2001.0395_RF48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cne.903390311","article-title":"Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: Comparison of the disector with an unfolding method","volume":"339","author":"Raadsheer","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/nbdi.2001.0395_RF49","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1176\/ajp.152.9.1372","article-title":"Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease","volume":"152","author":"Raadsheer","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1006\/nbdi.2001.0395_RF50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02741457","article-title":"Detrimental effects of chronic hypothalamic-pituitary adrenal axis activation","volume":"18","author":"Raber","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1006\/nbdi.2001.0395_RF51","first-page":"9","article-title":"Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J. Clin. Psychiatry"},{"key":"10.1006\/nbdi.2001.0395_RF52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0960-0760(91)90168-5","article-title":"Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: Neuroendocrine activity and corticosteroid receptors","volume":"40","author":"Reul","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1006\/nbdi.2001.0395_RF53","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1523\/JNEUROSCI.11-12-03695.1991","article-title":"Inhibition of glucocorticoid secretion by the hippocampal formation in the primate","volume":"11","author":"Sapolsky","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2001.0395_RF54","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1073\/pnas.93.19.10477","article-title":"CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors","volume":"93","author":"Schulz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2001.0395_RF55","series-title":"Neurochemistry: A Practical Approach","first-page":"121","article-title":"In situ hybridization approaches to the study of the nervous system","author":"Seroogy","year":"1997"},{"key":"10.1006\/nbdi.2001.0395_RF56","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"10.1006\/nbdi.2001.0395_RF57","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1471-4159.1998.70052212.x","article-title":"Amyloid-\u03b2 deposition in Alzheimer transgenic mice is associated with oxidative stress","volume":"70","author":"Smith","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2001.0395_RF58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-8993(94)91485-0","article-title":"Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischemia or activation of NMDA receptors in the rat brain","volume":"656","author":"Strijbos","year":"1994","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2001.0395_RF59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2001.0395_RF60","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and \u03b2-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"10.1006\/nbdi.2001.0395_RF61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0960-0760(91)90290-L","article-title":"Brain corticosteroid receptor gene expression and neuroendocrine dynamics during aging","volume":"40","author":"van Eekelen","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1006\/nbdi.2001.0395_RF62","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1210\/en.137.12.5747","article-title":"In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation","volume":"137","author":"Webster","year":"1996","journal-title":"Endocrinology"},{"key":"10.1006\/nbdi.2001.0395_RF63","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0006-3223(97)00165-0","article-title":"Cortisol secretion and Alzheimer's disease progression","volume":"42","author":"Weiner","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1006\/nbdi.2001.0395_RF64","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/00001756-199509000-00019","article-title":"Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala","volume":"6","author":"Wong","year":"1995","journal-title":"Neuroreport"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610190395X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610190395X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T09:55:03Z","timestamp":1576490103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999610190395X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S096999610190395X"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.2001.0395","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}